6-methyladenine has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Q; Qi, Y; Yao, R; Zhang, W | 1 |
1 other study(ies) available for 6-methyladenine and Diabetic Retinopathy
| Article | Year |
|---|---|
KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.
Topics: Adenine; Animals; Cell Proliferation; Cells, Cultured; Diabetic Retinopathy; Disease Models, Animal; Disease Progression; Endothelial Cells; Ependymoglial Cells; Focal Adhesion Kinase 1; Histone Acetyltransferases; Integrin beta1; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Streptozocin | 2021 |